... and it also snapped up D-Target, a Swiss CRO that specialises in clinical research and ... chairman Peter Fellner. "However the recent difficult stock market conditions and the reduced availability of debt ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment